课题基金 / 基金详情

Replacement of ganglion cells through regeneration - structural and functional analysis of cell integration

Replacement of ganglion cells through regeneration - structural and functional analysis of cell integration
通过再生替代神经节细胞 - 细胞整合的结构和功能分析
批准号:
30964419
负责人:
Dr. Mike O. Karl
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2006
资助国家:
德国
项目状态:
已结题
起止时间:
2005-12-31 至 2008-12-31

项目摘要

项目成果

Dr. Mike O. Karl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The ocular hypertension that frequently characterizes glaucoma, ultimately causes blindness because retinal ganglion cells degenerate. Although many studies have focused on prevention of ocular hypertension or investigated potential ways to protect ganglion cells from degeneration, relatively few studies have investigated the possibility of stimulating ganglion cell regeneration. Some animals are capable of regenerating new ganglion cells after they are lost. Fish and amphibians can regenerate their retinas almost perfectly and regain a high degree of normal function. Unfortunately, mammals (including humans) do not possess this capability, and so when the retinal ganglion cells are lost in degenerative disorders like glaucoma, these neurons are never restored. It is an overall goal to discover the molecular and cellular roadblocks that limit regeneration in mammals, with an eye towards re-initiating this process to treat various types of retinal degenerations. The experiments proposed in this application represent a first attempt to determine the feasibility of stimulating the very minimal repair that exists in the mammalian retina to produce new retinal ganglion cells. Prof. Reh´s group found that the appropriate timing and combination of intraocular injections of growth factors can restore some of the ganglion cells lost through experimental neurotoxin treatment in the chick retina. The experiments proposed might tell us whether we can use the same approach in the mammalian retina and serve as a foundation for developing new therapies for the treatment of glaucoma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing photoreceptor cell replacement therapies in human retinal pathology models: mechanisms of cell integration
  • 批准号:
    399487982
  • 项目类别:
    Priority Programmes
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Dr. Mike O. Karl
  • 依托单位:
国内基金
海外基金
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
  • 批准号:
    82371224
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马柯
  • 依托单位: